Yudapa Duo Sustained Release Tablet 10/1000 mg

Adult dose

This medication is generally administered once daily with the evening meal. The maximum dosage is 1 daily dose of Dapagliflozin 10 mg/Sustained Release Metformin 2000 mg, taken as 2 tablets of 5 mg/1000 mg. When used as initial therapy, one tablet of 5 mg/500 mg or 10 mg/500 mg is administered once daily. To reduce gastrointestinal side effects from metformin, the dosage should be gradually increased. Metformin.

This medication is helpful in controlling blood sugar. However, this medication can rarely cause a dangerous condition known as lactic acidosis, so caution is necessary. When taken with other diabetes medications, hypoglycemia may occur, so monitoring blood sugar changes is essential. Patients with poor kidney function, dehydration, severe infections, or heart issues should not take this medication. Additionally, pregnant or breastfeeding women and patients with genetic lactose intolerance should avoid it. Patients with reduced fluid volume or kidney function issues should have their condition carefully assessed before administration, and blood pressure and kidney function should be regularly monitored during usage. While taking this medication, genital infections or urinary tract infections may occur, so prompt treatment is necessary when symptoms arise. Also, hypoglycemic symptoms may appear; hence dose adjustments may be necessary when taken alongside insulin or blood sugar-lowering agents. Long-term use may lead to vitamin B12 deficiency, so regular monitoring of vitamin levels is advisable. Alcohol intake may increase the risk of side effects, so care should be taken to avoid excessive drinking. If undergoing surgery or radiological contrast tests, this medication should be discontinued for a period and restarted only after confirming normal kidney function. In the elderly, decreased kidney function is common, so dosage should be carefully adjusted and kidney function monitored regularly. In case of overdose, immediate consultation with healthcare personnel for appropriate treatment is needed, and although this medication has a minimal effect on driving or operating machinery, caution is necessary due to the potential for dizziness. Keep the medication out of reach of children and store it in its original container to maintain quality.

Serious side effects

Severe lactic acidosis (associated with metformin hydrochloride), severe hypoglycemia, decreased fluid volume (dehydration, hypovolemia, hypotension), diabetic ketoacidosis, urosepsis and pyelonephritis, acute kidney injury and renal impairment, rash (severe skin reactions), hepatic disorders (associated with jaundice), Guillain-Barré syndrome, acute cholecystitis, atrial fibrillation, heart disorders, perineal necrosis (Fournier's gangrene), sudden and severe headache, thunderclap headache, seizures, confusion.

Mild side effects

Vulvitis, balanitis and related genital infections, urinary tract infections, fungal infections, hypoglycemia (when used with sulfonylureas or insulin), dry mouth, dizziness, constipation, back pain, dysuria, polyuria, nocturia, vulvar itching, genital itching, elevated hematocrit, initial decrease in renal creatinine clearance, dyslipidemia, initial rise in blood creatinine, increase in blood urea, weight loss

This medication should be kept in a tightly closed container to avoid exposure to air or moisture. It is also preferable to store it at room temperature between 1 to 30 degrees Celsius, away from excessively hot or cold environments.

Appearance

Yellow, oval-shaped, bilayered sustained release film-coated tablet

Package unit

30 tablets/bottle